v3.26.1
Fair Value (Tables)
3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following fair value hierarchy tables present information about each major category of the Company’s financial assets and liabilities measured at fair value on a recurring basis (in thousands):
 Fair Value Measurement at March 31, 2026
 Fair ValueLevel 1Level 2Level 3
Assets
Money market funds$136,733 $136,733 $— $— 
Total assets at fair value$136,733 $136,733 $— $— 
 Fair Value Measurement at December 31, 2025
 Fair ValueLevel 1Level 2Level 3
Assets
Money market funds$9,244 $9,244 $— $— 
Total assets at fair value$9,244 $9,244 $— $— 
 Fair Value Measurement at March 31, 2026
Fair ValueLevel 1Level 2Level 3
Liabilities
SARs liability$2,710 $— $— $2,710 
Stock options granted subject to shares available liability1,123 — — 1,123 
Total Liabilities$3,833 $— $— $3,833 
 Fair Value Measurement at December 31, 2025
Fair ValueLevel 1Level 2Level 3
Liabilities
SARs liability$809 $— $— $809 
Total Liabilities$809 $— $— $809 
Schedule of Fair Value of Tranche Rights A rollforward of the fair value of the SARs liability is as follow (in thousands)
Fair value of SARs liability at December 31, 2025$809 
Change in fair value of SARs liability1,901 
Fair value of SARs liability at March 31, 2026$2,710 
A rollforward of the fair value of the Stock Options issued subject to shares available liability is as follows (in thousands):
Fair value of stock options granted subject to shares available liability at December 31, 2025$— 
Stock options granted subject to shares available liability1,123 
Fair value of stock options granted subject to shares available liability at March 31, 2026$1,123 
Schedule of Valuation Assumptions Used
The following table summarizes the key assumptions used in estimating the fair value of the SARs on March 31, 2026 and December 31, 2025:
March 31, 2026December 31, 2025
Expected term (years)
1.08-2.96
1.00-2.40
Risk-free interest rate
3.75%-4.21%
3.64%-4.11%
Stock price volatility
80%-115%
65%-115%
Probability (1)
50%-50%
50%-50%
Dividend rate
—%
—%

(1) Scenario probability was based on timing expectations of the Company that a corporate transaction occurring was estimated at 50%; and a corporate transaction not occurring at 50%.
The following are the underlying assumptions used in the Black-Scholes option pricing model to determine the fair value of stock options granted to employees and to non-
employees under this stock plan. The expected term of the options for the three months ended March 31, 2025 includes a grant to a non-employee consultant where the term of the option is five years compared to employee grants that are ten years:
Three Months Ended March 31,
20262025
Risk-free interest rate3.81%4.36%
Expected dividend yield0%0%
Expected volatility111.0%95.2%
Expected term of options (years)6.103.50
The following table summarizes the key assumptions used in estimating the fair value of the SARs at March 31, 2026 and December 31, 2025:

March 31, 2026December 31, 2025
Expected term (years)
1.08-2.96
1.00-2.40
Risk-free interest rate
3.75%-4.21%
3.64%-4.11%
Stock price volatility
80%-115%
65%-115%
Probability (1)
50%-50%
50%-50%
Dividend rate
—%
—%

(1) Scenario probability was based on timing expectations of the Company that a corporate transaction occurring was estimated at 50%; and a corporate transaction not occurring at 50%.